TECH vs REGN: Which Stock is Better?
Side-by-side comparison of Bio-Techne Corp and Regeneron Pharmaceuticals Inc in 2026
TECH
Bio-Techne Corp
$59.00
REGN
Regeneron Pharmaceuticals Inc
$766.66
Key Metrics Comparison
| Metric | TECH | REGN | Winner |
|---|---|---|---|
| Market Cap | $9.23B | $83.60B | REGN |
| P/E Ratio | 111.32 | 19.05 | REGN |
| EPS (TTM) | $0.53 | $41.52 | REGN |
| Revenue Growth | -0.0% | 0.0% | REGN |
| Gross Margin | 66.6% | 44.6% | TECH |
Analyze TECH
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TECH or REGN a better investment?
Comparing TECH and REGN: Bio-Techne Corp has a market cap of $9.23B while Regeneron Pharmaceuticals Inc has $83.60B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TECH and REGN?
TECH (Bio-Techne Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TECH or REGN?
Based on P/E ratios, REGN trades at a lower multiple (19.0x vs 111.3x).
Which is growing faster: TECH or REGN?
REGN has higher revenue growth at 0.0% vs -0.0% for TECH.
Which company is more profitable: TECH or REGN?
Bio-Techne Corp (TECH) has higher gross margins at 66.6% compared to 44.6% for REGN.
Which is the larger company: TECH or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $83.60B compared to $9.23B for TECH.
Should I buy TECH or REGN in 2026?
Both TECH and REGN have investment merit. TECH trades at $59.00 while REGN trades at $766.66. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TECH and REGN stock?
Key differences: Market Cap ($9.23B vs $83.60B), P/E Ratio (111.3x vs 19.0x), Revenue Growth (-0.0% vs 0.0%), Gross Margin (66.6% vs 44.6%).